Furthermore, FGFR1/β-Klotho activation mediates the enhancement of energy expenditure, insulin sensitization, and the induction of high-molecular-weight adiponectin for the treatment of obesity-related metabolic disorders40. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.